Barinthus Biotherapeutics plc. CEO William Enright's 2022 pay falls 24% to $2.1M
Barinthus Biotherapeutics plc. reports 2022 executive compensation
By ExecPay News
Published: March 29, 2023
Barinthus Biotherapeutics plc. reported fiscal year 2022 executive compensation information on March 29, 2023.
In 2022, four executives at Barinthus Biotherapeutics plc. received on average a compensation package of $1.1M, a 62% decrease compared to previous year.
Average pay of disclosed executives at Barinthus Biotherapeutics plc.
William Enright, Chief Executive Officer, received $2.1M in total, which decreased by 24% compared to 2021. 56% of Enright's compensation, or $1.2M, was in option awards. Enright also received $291K in non-equity incentive plan, $569K in salary, as well as $56K in other compensation.
Meg Marshall, Chief Medical Officer, received a compensation package of $922K, which decreased by 71% compared to previous year. 50% of the compensation package, or $463K, was in salary.
Graham Griffiths, Chief Business Officer, earned $754K in 2022.
Thomas Evans, Chief Scientific Officer, received $753K in 2022.
Related executives
You may also like
Source: SEC filing on March 29, 2023.